In a new report issued by Allied Market Research, world medical tourism is projected to become a $143.8 billion market by 2022. The market continues to receive growth from factors such as medical care affordability and accessibility in countries other than travelers’ own. Increases in cases of cancer, neurological ailments requiring treatment from specialists and stress-induced illnesses are also boosting the search for more affordable, safer treatments in other countries.

North America and Asia Pacific dominate the medical tourism market, due to affordable care found in Mexico, Thailand, Malaysia, India and Singapore. Following close behind Asia Pacific is the LAMEA region (Latin America, Middle East and Africa), both of which show increasing treatment success rates. As medical tourism in these regions grows, travel agencies tailored to medical tourism are popping up to market specific destinations to travelers and provide assistance arranging medical services.

Over the next six years, the report expects overall world medical tourism to increase by a compound annual growth rate of 15.7 percent, with medical tourism for cancer treatment increasing by 16 percent and medical tourism for neurological treatment increasing by 16.2 percent.